Investors’ Patience Is Being Tested Right Now By Esperion Therapeutics Inc. (NASDAQ: ESPR)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted RFK, Esperion Therapeutics Announce 2024 Promotional Schedule.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

Esperion Therapeutics Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $2.19 and fluctuated between $2.2100 as its day high and $2.0250 as its day low. The current market capitalization of Esperion Therapeutics Inc. is $373.22M. A total of 4.65 million shares were traded on the day, compared to an average of 5.95M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, ESPR has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 17 BUYs and 14 SELLs from insiders. Insiders purchased 286,561 shares during that period but sold 30,004.

In the most recent transaction, Warren Eric sold 742 shares of ESPR for 1.25 per share on Sep 20. After the transaction, the Chief Commercial Officer now owns 68,318 company shares. In a previous transaction on Aug 18, Warren Eric sold 243 shares at 1.41 per share. ESPR shares that Chief Commercial Officer owns now total 69,060.

Among the insiders who sold shares, Warren Eric disposed of 106 shares on Jul 19 at a per-share price of $1.58. This resulted in the Chief Commercial Officer holding 69,303 shares of ESPR after the transaction. In another insider transaction, Warren Eric sold 603 shares at $1.48 per share on Jun 21. Company shares held by the Chief Commercial Officer now total 69,409.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for ESPR in the last 3 months, the mean price target is $8.54 with high estimates of $22.00 and low estimates of $2.80. In terms of 52-week highs and lows, ESPR has a high of $6.74 and a low of $0.70.

As of this writing, ESPR has an earnings estimate of -$0.47 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.34 per share and a lower estimate of -$0.62. The company reported an EPS of -$0.46 in the last quarter, which was 24.60% higher than expectations of -$0.61.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ESPR’s latest balance sheet shows that the firm has $259.33M in Cash & Short Term Investments as of fiscal 2021. There were $260.20M in debt and $73.35M in liabilities at the time. Its Book Value Per Share was -$3.66, while its Total Shareholder’s Equity was -$196.94M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ESPR is Buy with a score of 4.13.

Most Popular

Related Posts